Patient Care and Research

ASTRO Guideline on Radiation Therapy for Glioblastoma

Published:  July 2016 (Web posted March 2016)

Read Executive Summary
Read Full-Text Guideline

The guideline addresses the following four areas regarding effective treatment of glioblastoma with radiation therapy: 1) when radiation is indicated following biopsy or resection of glioblastoma and how it is impacted by systemic therapy; 2) optimal dose-fractionation schemes for EBRT following biopsy or section and whether pretreatment characteristics like age or performance status affect appropriate fractionation; 3) ideal target volumes for curative-intent EBRT; and 4) the role of reirradiation in patients whose disease returns after initial treatment. 

Endorsed by:

  • American Society of Clinical Oncology

Key Points:

  • Ideal dose-fractionation and target volume design
  • Tumor-specific and patient-specific factors, including cytogenetics, performance status, and age, and the potential role of re-irradiation in recurrence


Imaging Brain Tumors: Practical Primer for the Radiation Oncologist (CME)
Challenging Cases to CNS Current Approaches (CME)

We have recently updated our privacy policy and terms of use.
By using this site, you agree to ASTRO’s Privacy Policy and Terms of Use.
We use cookies to provide, secure and improve our services to you. To learn more, click here.